Pre-exposure prophylaxis, or PrEP, is a daily medication or periodic injection that reduces the risk of contracting HIV by up to 99% when used as prescribed. More than 1.2 million Americans could benefit from PrEP, according to the CDC, but fewer than 40% currently use it. Cost is one reason for this gap.
PrEP list prices can appear overwhelming. Brand-name Descovy costs about $2,200 per month, while the newest injectable lists for more than $14,000 per dose. However, list prices rarely reflect what patients actually pay. Most insured Americans can receive PrEP without out-of-pocket costs, and uninsured patients may qualify for assistance programs or lower-cost options.
Four PrEP Options in 2026
The FDA has approved four medications for PrEP, each with a different dosing schedule and cost profile.
Medication | Type and Schedule | List Price | Typical Patient Cost |
|---|---|---|---|
Generic Truvada (TDF/FTC) | Daily pill | ~$1,600–1,800/month | $30–60/month with discounts |
Descovy (TAF/FTC) | Daily pill | ~$2,200/month | Often $0 with insurance or assistance |
Apretude (cabotegravir) | Injection every 2 months | ~$4,038/injection | Often $0 with ViiVConnect |
Yeztugo (lenacapavir) | Injection every 6 months | ~$14,109/injection | Often $0 with Gilead assistance |
Generic Truvada
Generic TDF/FTC is usually the least expensive option for people paying cash. Competition among manufacturers has lowered the price to about $30–60 for a 30-day supply through programs such as GoodRx. Some transparent-pricing pharmacies offer 90-day supplies for approximately $25–32 per month.
TDF-based PrEP has been associated with slightly greater risks of kidney and bone-density changes than newer options. People with kidney conditions should discuss this issue with a healthcare provider.
Descovy
Descovy is a newer daily pill with a more favorable kidney and bone safety profile. Its list price is about $2,200 per month, but insured patients commonly pay nothing under qualifying plans. Gilead's Advancing Access program may provide the medication free to eligible uninsured patients with household income at or below 500% of the federal poverty level.
Apretude and Yeztugo
Apretude is given by a healthcare provider every two months. ViiVConnect may cover the cost for eligible insured and uninsured patients. Injection-site pain, swelling, and redness are common side effects.
Yeztugo, approved in June 2025, is given twice a year. This schedule may benefit people who find daily pills difficult to maintain. Although its list price is about $14,109 per injection, eligible patients may receive copay or patient assistance from Gilead.
PrEP Coverage with Insurance
Most ACA-compliant private health plans must cover PrEP preventive services without cost-sharing. Coverage generally includes the medication, required clinic visits, and laboratory tests. This rule applies to marketplace plans and most employer-sponsored insurance, although grandfathered plans may operate differently.
All state Medicaid programs cover PrEP, usually with copays between $0 and $3 when a copay applies. Injectable medications may require prior authorization, so patients should confirm coverage before scheduling treatment.
Since 2024, Medicare Part B has covered FDA-approved oral and injectable PrEP without cost-sharing. Coverage includes medication, injection administration, HIV testing, and adherence counseling. Medicare Part D plans may also cover PrEP, but individual terms vary.
Insurance rules can change. Patients should check current plan details during open enrollment and confirm whether prior authorization or specific providers are required.
Affordable PrEP Without Insurance
Uninsured patients have several possible routes to affordable care.
Gilead Advancing Access may provide Descovy or generic Truvada at no charge to eligible patients at or below 500% of the federal poverty level. The program covers medication but not necessarily clinic visits or laboratory work. Applicants can apply online or call 1-800-226-2056.
ViiVConnect offers free Apretude to eligible uninsured patients under similar income guidelines. A healthcare provider must complete part of the enrollment application.
Some telehealth providers use the federal 340B Drug Pricing Program to offer online consultations, at-home laboratory kits, medication, and delivery at little or no cost. MISTR is one example. Other services, including Nurx and PlushCare, have different pricing structures, so patients should review the full cost before enrolling.
People who do not qualify for manufacturer assistance may use pharmacy discount programs for generic Truvada. Federally Qualified Health Centers, local health departments, and community clinics may offer laboratory testing and visits on a sliding fee scale.
More than 25 states also operate PrEP assistance programs. Eligibility and benefits differ by location. Some programs cover medication copays, coinsurance, or deductibles for residents who meet income requirements. NASTAD maintains a directory of state programs.
Costs Beyond Medication
Starting and continuing PrEP requires testing and follow-up care. For uninsured patients, an initial workup—including HIV, kidney function, hepatitis B, and STI screening—may cost $200–800. Follow-up testing every three months may cost $150–400 per visit. Injectable treatment may add administration costs of $50–200 per appointment.
Manufacturer programs often cover only the medication. Patients may need a community clinic, health department, or 340B provider to reduce laboratory and visit expenses. Before choosing a program, ask whether its quoted price includes prescriptions, testing, consultations, injection fees, and delivery.
Choosing the Right Option
The best PrEP option depends on insurance, income, medical history, and preferred schedule. Insured patients may be able to focus on medical fit rather than price. People concerned about kidney health may discuss Descovy or an injectable with their provider. Those who struggle with daily adherence may prefer Apretude or twice-yearly Yeztugo.
For uninsured patients with lower incomes, combining manufacturer medication assistance with a community clinic or 340B service may create a complete low-cost pathway. Those above assistance-program income limits may find generic Truvada plus sliding-scale testing to be the most affordable approach.
PrEP is one of the most effective tools for preventing HIV, and its list price does not necessarily determine its real cost. Insurance mandates, manufacturer programs, telehealth services, pharmacy discounts, and state assistance can make treatment affordable or free. Patients should compare complete costs and discuss medical suitability with a qualified healthcare provider before selecting an option.